Midatech appoints former GSK director to the board
Midatech said it is "very confident" Frédéric Duchesne will make an "important and positive impact" to the business
Company
GSK PLC
LON:GSK
GSK PLC will be a fully focused biopharma company following the demerger of its world-leading consumer healthcare business, Haleon, in July 2022. The company will prioritise innovation in vaccines and specialty medicines, maximising the increasing opportunities to prevent and treat disease.
746 stories · page 20 of 38
Investments and investor services
FTSE 100 closes in the red as traders await first US rate cut since recession
Investors are expecting a cut of 0.25% in the benchmark short-term rate
GlaxoSmithKline lifts full-year guidance as profits double in second quarter
GSK was forced to cut its forecasts earlier this ear after a generic rival to Advair came to market, but an “improved operational performance” in the second quarter means things won’t be as bad as first feared
GSK names former AstraZeneca finance boss as new chairman
Jonathan Symonds will be the man tasked with overseeing the mega merger of GSK and Pfizer’s consumer healthcare businesses
Investments and investor services
FTSE 100 closes in red as mining stocks weigh
FTSE 100 closed in the red on Wednesday as miners weighed after a sell-off in iron ore in China
Archive
ITV investors watching for Love Island effect as new boy enters villa
The Conservative Party leadership contest was decided by a relatively convincing margin of 92,153 votes to 46,656, while Love Island commands consolidated viewing figures of more than 5mln
Investments and investor services
FTSE 100 regains positive footing at close as Wall Street makes gains
In New York, the Dow Jones Industrials Average hit 27,153 by midday, while the S&P gained 0.2% and the Nasdaq was up 0.6%.
Archive
ITV investors hope for Love Island boost amid tough ad market
The week ahead includes updates from ITV, Unilever, Rightmove, Diageo, Marston's, IG Group, National Express, GSK and AstraZeneca
GlaxoSmithKline edges higher as Zejula passes late-stage ovarian cancer study with flying colours
Zejula demonstrated a “statistically significant” improvement in progression free survival – the length of time a patient lives with the disease but it doesn’t get worse
Verona Pharma: The AIM-quoted drug developer built on the research of a Glaxo legend
Sir David Jack's team were responsible for the discovery of several huge drugs, and RPL554, a compound he helped develop later on in his career, is now being taken through the clinic by Verona
GSK’s Dovato single-pill HIV treatment sails through year-long phase III trial
GSK wanted to show that Dovato was just as effective in suppressing HIV as the current cocktail of drugs given to HIV sufferers
Archive
Barratt Developments and Bovis Homes to provide main building bricks in coming week
Aside from the two housebuilders, corporate updates in the coming week will also be delivered by retailers Ocado, Superdry and Dunelm
Morgan Stanley doesn’t think there’s much money to be made by investing in GSK
GSK is in the middle of some big changes: it is bedding in a multi-billion-dollar acquisition; rebuilding its drugs pipeline; and merging its consumer healthcare division with one of its rivals
GlaxoSmithKline gets US green light for severe asthma home treatment
The Food & Drug Administration gave approval for GSK’s Nucala to be given using an auto-injector or a pre-filled safety syringe
Immuno-oncology: All you wanted to know but were too afraid to ask
Essentially, immuno-oncology involves developing drugs that use the body’s own immune system to fight cancers
Investments and investor services
FTSE 100 closes firmly higher as Wall Street shares head north; sterling slides
The UK benchmark index closed over 56 points higher, at 7,353, aided by the fall in the pound
Archive
Burberry and Thomas Cook in the spotlight; ex-divs to take 26 points off the FTSE 100
Numbers from Countryside Properties, National Grid, and Wincanton will also be among Thursday's highlights.
Archive
Burberry, Kingfisher, Thomas Cook and Aston Martin in focus in week ahead
The week ahead's highlights include updates from Burberry, Land Securities, British Land, Premier Foods, Experian, Kingfisher, Aston Martin, Dignity, Centrica, Thomas Cook, On the Beach and Countryside Properties.
Pharma stocks head south as Trump forces them to display drug prices in TV ads
“Drug companies have to come clean about their prices in TV ads. If drug companies are ashamed of those prices – lower them!”
Vectura surges as it wins US$90mln patent battle with GlaxoSmithKline
GSK has been ordered to pay US$89.7mln after its Ellipta inhalers were found to have breached Vectura’s patents